Literature DB >> 8429545

Serum and tissue protein binding and cell surface properties of Staphylococcus lugdunensis.

M Paulsson1, A C Petersson, A Ljungh.   

Abstract

Eleven strains of Staphylococcus lugdunensis from different clinical sources were investigated for their ability to bind 125I-labelled collagen (Cn) type I and IV, fibronectin (Fn), vitronectin (Vn), laminin (Lm), fibrinogen (Fg), thrombospondin, plasminogen (glu- and lys-form) and human IgG. All the strains bound these proteins, although a higher degree of binding was obtained for Cn types I and IV and IgG with mean values of 36%, 32% and 26% binding, respectively. In tests with proteins immobilised on latex beads in a particle agglutination assay, eight of the 11 strains bound Cn type I and seven bound Fg, whereas no strain bound immobilised IgG. Binding to immobilised Cn-I, Fg, Lm and Vn was abolished when the bacterial cells were treated with proteases or heat, indicating cell-surface receptors with protein characteristics. Cell-surface extracts of S. lugdunensis 2342 were able to totally inhibit binding of the homologous strain and S. aureus Cowan 1 to latex-immobilised proteins Cn-I, Lm, Vn, Fn and Fg. The binding of 125I-labelled Cn IV by S. lugdunensis 2342, was heat sensitive, whereas the binding to S. aureus Cowan 1 was heat resistant. The strains gave negative results in tests for the presence of protein A with a S. aureus protein A gene probe and with sensitised red blood cells. No production of heat-stable nuclease (TNase) could be detected by monoclonal antibodies against TNase or by the polymerase chain reaction with an oligonucleotide sequence from S. aureus TNase as primer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429545     DOI: 10.1099/00222615-38-2-96

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Mitral and aortic valve endocarditis due to Staphylococcus lugdunensis.

Authors:  A Renzulli; A Della Corte; M Torella; G Dialetto; M Cotrufo
Journal:  Tex Heart Inst J       Date:  2000

2.  Staphylococcus lugdunensis Endocarditis: Lower Mortality in the Contemporary Era?

Authors:  Benjamin T Leis; Dwip D Parekh; Brendon F Macknak; Siddharth Kogilwaimath
Journal:  CJC Open       Date:  2022-02-03

3.  Vertebral osteomyelitis due to Staphylococcus lugdunensis.

Authors:  D R Murdoch; R J Everts; S T Chambers; I A Cowan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 4.  From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis.

Authors:  Kristi L Frank; José Luis Del Pozo; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.

Authors:  Kristi L Frank; Robin Patel
Journal:  Infect Immun       Date:  2007-07-16       Impact factor: 3.441

Review 6.  Update on clinical significance of coagulase-negative staphylococci.

Authors:  W E Kloos; T L Bannerman
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

7.  Fulminant staphylococcus lugdunensis septicaemia following a pelvic varicella-zoster virus infection in an immune-deficient patient: a case report.

Authors:  M Woznowski; I Quack; E Bölke; M Peiper; C Matuschek; S G Gatermann; L C Rump; Gisela Schieren
Journal:  Eur J Med Res       Date:  2010-09-24       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.